Light therapy tested to shield patients from dangerous transplant complication
NCT ID NCT03204721
Summary
This study tested if a special light-based blood treatment could prevent a serious complication called graft-versus-host disease (GVHD) in patients receiving a stem cell transplant for blood cancer. Researchers compared this treatment, which has milder side effects, to standard preventive drugs. The goal was to see if it could reduce how often GVHD occurs in the first year after transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT -VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tobias Gedde-Dhl
Oslo, Norway
Conditions
Explore the condition pages connected to this study.